Chemours Co (CC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 2.5B 5B 7.5B FY13: 6.9B FY14: 6.4B FY15: 5.7B FY16: 5.4B FY17: 6.2B FY18: 6.6B FY19: 5.5B FY20: 5B FY21: 6.3B FY22: 6.8B FY23: 6.1B FY24: 5.8B FY25: 5.8B FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 700M 1.4B 2.1B FY13: 1.5B FY14: 1.4B FY15: 955M FY16: 1.1B FY17: 1.7B FY18: 2B FY19: 1.1B FY20: 1.1B FY21: 1.4B FY22: 1.6B FY23: 1.3B FY24: 1.1B FY25: 902M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income Annual

-700M -350M 0 350M 700M 1.1B FY13: 423M FY14: 400M FY15: -90M FY16: 7M FY17: 746M FY18: 995M FY19: -52M FY20: 219M FY21: 608M FY22: 578M FY23: -253M FY24: 69M FY25: -386M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 2B 4B 6B FY16: 4.3B FY17: 4.4B FY18: 4.7B FY19: 4.5B FY20: 3.9B FY21: 5B FY22: 5.2B FY23: 4.8B FY24: 4.6B FY25: 4.9B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-800M -400M 0 400M 800M 1.2B FY13: 798M FY14: 505M FY15: 182M FY16: 594M FY17: 640M FY18: 1.1B FY19: 650M FY20: 807M FY21: 814M FY22: 755M FY23: 556M FY24: -633M FY25: 264M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-1.1B -700M -350M 0 350M 700M 1.1B FY13: 360M FY14: -99M FY15: -337M FY16: 256M FY17: 229M FY18: 642M FY19: 169M FY20: 540M FY21: 537M FY22: 448M FY23: 186M FY24: -993M FY25: 51M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 70M 140M 210M FY13: 181M FY14: 181M FY15: 181M FY16: 183.4M FY17: 191M FY18: 182.6M FY19: 164.8M FY20: 166.3M FY21: 168.7M FY22: 158.3M FY23: 148.9M FY24: 150.2M FY25: 150.2M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.00 -2.00 0.00 2.00 4.00 6.00 Q4 '14: 2.21 Q1 '15: 1.91 Q2 '15: 1.17 Q3 '15: 0.42 Q4 '15: -0.50 Q1 '16: -0.46 Q2 '16: -0.46 Q3 '16: 0.81 Q4 '16: 0.03 Q1 '17: 0.54 Q2 '17: 1.48 Q3 '17: 1.45 Q4 '17: 3.90 Q1 '18: 4.69 Q2 '18: 5.38 Q3 '18: 5.81 Q4 '18: 5.43 Q1 '19: 4.40 Q2 '19: 3.44 Q3 '19: 2.39 Q4 '19: -0.36 Q1 '20: -0.30 Q2 '20: -0.72 Q3 '20: -0.72 Q4 '20: 1.33 Q1 '21: 1.29 Q2 '21: 1.53 Q3 '21: 2.34 Q4 '21: 3.62 Q1 '22: 4.48 Q2 '22: 5.35 Q3 '22: 5.60 Q4 '22: 3.56 Q1 '23: 3.09 Q2 '23: -0.69 Q3 '23: -2.13 Q4 '23: -1.60 Q1 '24: -2.20 Q2 '24: 0.71 Q3 '24: 0.41 Q4 '24: 0.45 Q1 '25: 0.06 Q2 '25: -2.86 Q3 '25: -2.24 Q4 '25: -2.47 Q1 '26: -2.63 Q2 '26: -1.91 Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.